About Sandstone Diagnostics
Sandstone Diagnostics was a Healthcare company based in Pleasanton (United States) founded in 2012 by Ulrich Schaff and Greg Sommer. It provides rapid tests for accurate sperm count diagnostics. It operates on a B2B model. Sandstone Diagnostics has raised $11.97 million across 5 funding rounds from investors including LabCorp, NIH and HHS. The company is recorded as dissolved. Its focus areas include Medical Devices, Diagnostics and Fertility Testing. Its competitors include Androvia LifeSciences and SCOPESCREEN.
Company details
Sandstone Diagnostics provides rapid tests for accurate sperm count diagnostics through providing healthcare solutions, developing medical devices, offering diagnostic solutions, and fertility testing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Pleasanton, United States
- Founders Ulrich Schaff, Greg Sommer
- SectorsHealthcare
- Website sandstonedx.com
- Social X
- Total Equity Funding$11.97M (USD)
in 5 rounds
- Latest Funding Round$2.42M (USD), Series A
May 2019
- InvestorsLabCorp
& 8 more
Funding Insights of Sandstone Diagnostics
Sandstone Diagnostics has successfully raised a total of $11.97M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.42 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.97M
- Total Rounds 5
- Last Round Series A — $2.42M
- First Round $1.26M
(Jun 2014)
- Investors Count 7
All 9 funding rounds of Sandstone Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2019 | $2.42M | Series A | – | – | |
| Jan 2018 | $5.94M | Series A | – | Astia | |
| Jan 2018 | Debt – Conventional | – | – | – | |
| Nov 2016 | $845,000 | Series A | – | – | – |
| Aug 2014 | $1.5M | Series A | – | Life Science Angels, Astia | – |
| Jul 2014 | $150,000 | Grant | – | – | |
| Jun 2014 | $1.26M | Seed | – | – | – |
| Sep 2013 | $149,189 | Grant | – | – | |
| Aug 2013 | $150,000 | Grant | – | – |
9 investors in total: 9 institutional.
Investors in Sandstone Diagnostics
Sandstone Diagnostics has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include LabCorp, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| cavendishfoundation.org | ||||
Women-led startups are funded through stage-agnostic investments and angel networks. | astia.org | San Francisco, United States | ||
Buyouts and growth equity investments are pursued across multiple sectors. | 1969 | dpwholdings.com | Fremont, United States | |
A family investment office focused on early-stage ventures. | jhuntholdings.com | |||
Life sciences startups are funded by a non-profit angel network. | lifescienceangels.com | Sunnyvale, United States | ||
Angel funding is provided to Silicon Valley-based companies. | sandhillangels.com | Mountain View, United States | ||
Provider of laboratory tests for physicians | 1969 | labcorp.com | Burlington, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Sandstone Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sandstone Diagnostics
17 people are tracked at Sandstone Diagnostics (4 in leadership, 8 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Ulrich Schaff | Co-Founder, CTO | Leadership |
Greg Sommer | Co-Founder, CSO | Leadership |
Gary Altman | CEO | Leadership |
Brian Awabdy | VP, Operations & Quality | Leadership |
Bob Easton | Director | Board & advisors |
Beto Pallares | Director | Board & advisors |
Steven Lipkin | Advisor | Board & advisors |
Elizabeth Hutt Pollard | Advisor | Board & advisors |
Joseph Alukal | Advisor | Board & advisors |
Faith Charles | Director | Board & advisors |
Priya Balachandran | Advisor | Board & advisors |
Michael Eisenberg | Advisor | Board & advisors |
Jon Epperson | Operations & Research Associate | Team |
Jason Ragar | Mechanical Engineer | Team |
Bhumika Harshita | Senior QA Associate | Team |
Maggie Cruz | Office Manager | Team |
Kyungjin Hong | Senior Bioengineer | Team |
Complete people profiles for Sandstone Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sandstone Diagnostics
3 dated milestones of Sandstone Diagnostics across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Sandstone Diagnostics is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Series A, of $2.4M.
Competitors of Sandstone Diagnostics
Sandstone Diagnostics has 2 listed competitors in our database. They include Androvia LifeSciences and SCOPESCREEN.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| androvialifesciences.com | 2015 | New York, United States | Develops innovative biomarker-based assays for male fertility testing. | |||
| scopescreen.com | 1991 | Brighton, United States | Specialized medical products for male fertility evaluation are manufactured. |
Detailed competitors of Sandstone Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Sandstone Diagnostics (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sandstone Diagnostics
Sandstone Diagnostics was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Sandstone Diagnostics is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Sandstone Diagnostics is a funded company, having raised a total of $11.97M across 5 funding rounds to date. The company's 1st funding round was a Grant of $150K, raised on Jun 2014.
Sandstone Diagnostics provides rapid tests for accurate sperm count diagnostics through providing healthcare solutions, developing medical devices, offering diagnostic solutions, and fertility testing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Sandstone Diagnostics's top competitors include SCOPESCREEN and Androvia LifeSciences.
Sandstone Diagnostics has 9 investors. Key investors include LabCorp, NIH, HHS, DPW Holdings, and Cavendish Impact Foundation.